Success Metrics

Clinical Success Rate
86.7%

Based on 13 completed trials

Completion Rate
87%(13/15)
Active Trials
1(4%)
Results Posted
15%(2 trials)
Terminated
2(9%)

Phase Distribution

Ph phase_4
7
30%
Ph phase_3
3
13%
Ph phase_1
1
4%
Ph not_applicable
12
52%

Phase Distribution

1

Early Stage

0

Mid Stage

10

Late Stage

Phase Distribution23 total trials
Phase 1Safety & dosage
1(4.3%)
Phase 3Large-scale testing
3(13.0%)
Phase 4Post-market surveillance
7(30.4%)
N/ANon-phased studies
12(52.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

86.7%

13 of 15 finished

Non-Completion Rate

13.3%

2 ended early

Currently Active

1

trials recruiting

Total Trials

23

all time

Status Distribution
Active(2)
Completed(13)
Terminated(2)
Other(6)

Detailed Status

Completed13
unknown6
Terminated2
Enrolling by invitation1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
23
Active
1
Success Rate
86.7%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (4.3%)
Phase 33 (13.0%)
Phase 47 (30.4%)
N/A12 (52.2%)

Trials by Status

terminated29%
completed1357%
enrolling_by_invitation14%
recruiting14%
unknown626%

Recent Activity

Clinical Trials (23)

Showing 20 of 23 trialsScroll for more
NCT06014983Not Applicable

Efficacy and Adverse Side Effects of Two Forms of Iron in Pregnancy

Recruiting
NCT04931641Not Applicable

Potential of Prebiotic Galacto-oligosaccharides in Improving Efficacy and Safety of Oral Iron Supplementation in HIV-infected Children

Completed
NCT01656434Phase 3

Study of the Contraceptive Efficacy and Safety of a NOMAC-E2 Combined Oral Contraceptive (COC)(P06448)

Terminated
NCT06303531Not Applicable

Efficacious Iron for Iron Deficiency Anemia in Adults Aged ≥18 Years

Enrolling By Invitation
NCT05033483Not Applicable

Do Iron Supplements Impact the Gut Microbiome of Women of Reproductive Age?

Completed
NCT05456932Phase 4

Predicting Response to Iron Supplementation in Patients With Active Inflammatory Bowel Disease

Unknown
NCT05581420Not Applicable

Oral Versus Intravenous Iron in IBD Patients With Anti-inflammatory Therapy.

Unknown
NCT01975272Phase 4

The Use of Iron Therapy for Patients With Anemia After Caesarean Section

Terminated
NCT04163406Not Applicable

The Effect of Human Milk Oligosaccharides and Galacto-oligosaccharides on Iron Absorption in Kenyan Infants

Completed
NCT05278793Phase 4

The Efficacy of Intermittent Versus Daily Oral Iron Supplementation in Anaemic Pregnant Women.

Unknown
NCT04130828Phase 3

Thrice-weekly Versus Thrice-daily Oral Ferrous Fumarate Treatment in Adult Patients With Iron Deficiency Anemia

Completed
NCT04194255Not Applicable

The Effect of Different Prebiotics on Iron Absorption From High Dose Iron Supplements

Completed
NCT02228902Phase 4

Iron Absorption Trial

Completed
NCT03762148Not Applicable

Determination of a Dose-dependent Effect of GOS on Iron Absorption, and Addition of Vitamin C

Completed
NCT02271997Phase 4

Optimizing Iron Suppletion After Roux-en-Y Gastric Bypass

Completed
NCT03295851Phase 4

Preoperative Intravenous Iron Infusion to Reduce Post-surgical Complications: a Pilot Randomised Control Trial

Unknown
NCT02243735Phase 4

Trial Comparing Ferric(III)Carboxymaltose Infusion With Oral Iron Suppletion as Treatment of Anaemia

Unknown
NCT03212781Phase 3

Iron Dextran Versus Oral Iron for Treating Iron Deficiency Anemia in Pregnant Women

Completed
NCT02831712Not Applicable

Effect of Iron Status on Occurrence of Non-transferrin-bound Iron (NTBI) in Serum in Response to an Oral Iron Load

Unknown
NCT02096250Not Applicable

Iron Absorption in Haiti

Completed

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
23